Clinical Trials Update: Aug. 8, 2003
Depression Breast Cancer Uterine Fibroids
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch
A clinical research trial of a medication that may help people who are having difficulty shaking persistent feelings of sadness.
Volunteers can range in age from 18-64 with a current episode of depression lasting 12 weeks or more and who have not been diagnosed with bi-polar disorder, anxiety or schizophrenia. Research site located in Lakewood, Washington.
A study to determine the effectiveness of an oral drug for the treatment of metastatic breast cancer tumors that are known to overexpress the protein HER2/neu. Volunteers are needed with refractory stage IIIb or IV breast cancer and who have had no more than two prior regimens for metastatic breast cancer. Each regimen must have contained Herceptin. Research sites located throughout the United States.
A research study of a medication for uterine fibroids. Pre-menopausal women at age 18-52 who have heavy uterine bleeding, chronic pelvic pressure, and bladder or bowel problems may be eligible to participate.
The research site is in San Diego.
Copyright 2003 CenterWatch. All rights reserved.